213 related articles for article (PubMed ID: 23217524)
1. Bilateral occlusive retinal vasculitis in a patient with primary antiphospholipid antibody syndrome.
Turaka K; Bryan JS; Kwong HM; Ziemianski MC
Can J Ophthalmol; 2012 Dec; 47(6):e60-1. PubMed ID: 23217524
[No Abstract] [Full Text] [Related]
2. Bilateral cilioretinal artery occlusion in antiphospholipid syndrome.
Carrero JL; Sanjurjo FJ
Retina; 2006 Jan; 26(1):104-6. PubMed ID: 16395148
[No Abstract] [Full Text] [Related]
3. Consecutive central retinal artery and vein occlusions in primary antiphospholipid syndrome.
Levy J; Baumgarten A; Rosenthal G; Rabinowitz R; Lifshitz T
Retina; 2002 Dec; 22(6):784-6. PubMed ID: 12476107
[No Abstract] [Full Text] [Related]
4. Recurrent anterior uveitis and healed retinal vasculitis associated with multiple sclerosis.
Narayana KM; Agrawal R; Biswas J; Arjundas D
Indian J Ophthalmol; 2003 Mar; 51(1):77-9. PubMed ID: 12701867
[TBL] [Abstract][Full Text] [Related]
5. Hypopyon uveitis associated with systemic lupus erythematosus and antiphospholipid antibody syndrome.
Zink JM; Singh-Parikshak R; Johnson CS; Zacks DN
Graefes Arch Clin Exp Ophthalmol; 2005 Apr; 243(4):386-8. PubMed ID: 15864630
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and therapeutic challenges. Bilateral occlusive retinal vasculitis.
Cronin KM; Manning RA; Richards CP; Rothova A; Tabbara KF
Retina; 2012 Jul; 32(7):1428-34. PubMed ID: 22908381
[No Abstract] [Full Text] [Related]
7. [Retinal vasculopathy in systemic lupus erythematosus: a case of lupus vasculitis and a case of non-vasculitis venous occlusion].
Figueras-Roca M; Rey A; Mesquida M; Pelegrín L; Llorens V; Fontenla JR; Adán A
Arch Soc Esp Oftalmol; 2014 Feb; 89(2):66-9. PubMed ID: 24269411
[TBL] [Abstract][Full Text] [Related]
8. Combined retinal artery and vein occlusion in a patient with systemic lupus erythematosus and antiphospholipid syndrome.
Durukan AH; Akar Y; Bayraktar MZ; Dinc A; Sahin OF
Can J Ophthalmol; 2005 Feb; 40(1):87-9. PubMed ID: 15825539
[No Abstract] [Full Text] [Related]
9. Uveitis with retinal occlusive vasculitis and sensorineural hypoacusia as first symptoms of relapsing polychondritis.
Paroli MP; Priori R; Spinucci G; Abicca I; Valesini G
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S101-3. PubMed ID: 22410282
[TBL] [Abstract][Full Text] [Related]
10. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment.
Au A; O'Day J
Clin Exp Ophthalmol; 2004 Feb; 32(1):87-100. PubMed ID: 14746601
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab (Avastin) in idiopathic retinitis, vasculitis, aneurysms and neuroretinitis.
Akesbi J; Brousseaud FX; Adam R; Rodallec T; Nordmann JP
Acta Ophthalmol; 2010 Mar; 88(2):e40-1. PubMed ID: 19508455
[No Abstract] [Full Text] [Related]
12. Idiopathic retinal vasculitis, aneurysms, and neuroretinitis in a patient with antiphospholipid syndrome.
Kurz DE; Wang RC; Kurz PA
Arch Ophthalmol; 2012 Feb; 130(2):257-8. PubMed ID: 22332229
[No Abstract] [Full Text] [Related]
13. Antiphospholipid antibody syndrome.
Yang P; Kruh JN; Foster CS
Curr Opin Ophthalmol; 2012 Nov; 23(6):528-32. PubMed ID: 23042148
[TBL] [Abstract][Full Text] [Related]
14. Management of IRVAN syndrome with observation.
Basha M; Brown GC; Palombaro G; Shields CL; Shields JA
Ophthalmic Surg Lasers Imaging Retina; 2014 May; 45 Online():e18-22. PubMed ID: 24766157
[TBL] [Abstract][Full Text] [Related]
15. Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion after Brolucizumab Treatment.
Baumal CR; Bodaghi B; Singer M; Tanzer DJ; Seres A; Joshi MR; Feltgen N; Gale R
Ophthalmol Retina; 2021 Jun; 5(6):519-527. PubMed ID: 33007521
[TBL] [Abstract][Full Text] [Related]
16. Catastrophic antiphospholipid syndrome presenting as dilated cardiomyopathy with bilateral branch retinal artery thrombosis.
Mandal B; Rathore S; Douglas AF
Int J Clin Pract; 2000 Oct; 54(8):550-1. PubMed ID: 11198738
[TBL] [Abstract][Full Text] [Related]
17. Reperfusion of Retinal Vasculature With Improved Visual Acuity in Ischemic Occlusive Vasculitis.
Bomar JG; Branson SV; McClintic J; Kurup SK
JAMA Ophthalmol; 2016 Apr; 134(4):466-7. PubMed ID: 26891887
[No Abstract] [Full Text] [Related]
18. Association of Occlusive Retinal Vasculitis With Intravitreal Faricimab.
Li Y; Chong R; Fung AT
JAMA Ophthalmol; 2024 May; 142(5):489-491. PubMed ID: 38517431
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.
Kötter I; Zierhut M; Eckstein A; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Peter HH; Kanz L; Stübiger N
Adv Exp Med Biol; 2003; 528():521-3. PubMed ID: 12918755
[No Abstract] [Full Text] [Related]
20. Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation.
Dori D; Beiran I; Gelfand Y; Lanir N; Scharf J; Miller B; Brenner B
Am J Ophthalmol; 2000 Jan; 129(1):106-8. PubMed ID: 10653428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
